SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-275395
Filing Date
2023-11-13
Accepted
2023-11-13 08:10:53
Documents
16
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d893930d8k.htm   iXBRL 8-K 30860
2 EX-99.1 d893930dex991.htm EX-99.1 87804
3 EX-99.2 d893930dex992.htm EX-99.2 10539
7 GRAPHIC g893930im01.jpg GRAPHIC 4297
8 GRAPHIC g893930sp1a.jpg GRAPHIC 3292
  Complete submission text file 0001193125-23-275395.txt   278807

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA iobt-20231109.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20231109_lab.xml EX-101.LAB 17911
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20231109_pre.xml EX-101.PRE 11239
10 EXTRACTED XBRL INSTANCE DOCUMENT d893930d8k_htm.xml XML 3330
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 231395293
SIC: 2834 Pharmaceutical Preparations